Suppr超能文献

评估利拉鲁肽对两种癫痫发生动物模型中癫痫发作和行为改变发展的影响。

Evaluation of the effects of liraglutide on the development of epilepsy and behavioural alterations in two animal models of epileptogenesis.

机构信息

Science of Health Department, School of Medicine, University "Magna Graecia" of Catanzaro, Viale Europa e Germaneto, 88100 Catanzaro, Italy.

National Council of Research (CNR), Institute of Neurological Science, Catanzaro, Italy.

出版信息

Brain Res Bull. 2019 Nov;153:133-142. doi: 10.1016/j.brainresbull.2019.08.001. Epub 2019 Aug 27.

Abstract

Liraglutide (LIR) is a novel long-lasting glucagon-like peptide-1 (GLP-1) analogue that facilitates insulin signalling and shows also neuroprotective properties in different brain disease models. In this study, we explored the potential antiepileptogenic effects of LIR in two different animal models; namely, the mouse intrahippocampal kainic acid (KA) model of temporal lobe epilepsy and the WAG/Rij rat model of absence epileptogenesis. Moreover, we evaluated LIR effects on comorbidities in various behavioural tests. Mice with kainate-induced epilepsy were treated with LIR (300 μg/kg/day s.c.) for 4 weeks after status epilepticus and then evaluated for drug effects on seizure development and behavioural alterations, whereas WAG/Rij rats were treated for 17 weeks (starting at 30 days of age, before seizure onset) with LIR (300 μg/kg/day s.c.) in order to investigate whether an early chronic treatment was able to reduce the development of absence seizures and related comorbidities. Our results indicate that LIR was effective in reducing the development of spontaneous seizures in kainate-induced epilepsy; moreover, in this model, it prevented memory impairment and related anxiety-like behaviour in the open field (OF) test while in the forced swimming test (FST), LIR displayed an apparent pro-depressant effect that was instead related to reduced endurance as confirmed by rotarod test. In contrast, LIR was unable to modify the epileptogenic process underlying the development of absence seizures in WAG/Rij rats while being antidepressant in the FST in this strain. Our results indicate that LIR may represent a promising novel treatment to prevent and treat the epileptogenic process and its associated behavioural and cognitive alterations in some models of convulsive epilepsy characterized by neurodegeneration, since LIR effects are likely secondary to its recognised neuroprotective properties.

摘要

利拉鲁肽(LIR)是一种新型长效胰高血糖素样肽-1(GLP-1)类似物,可促进胰岛素信号转导,并在不同的脑部疾病模型中显示出神经保护特性。在这项研究中,我们在两种不同的动物模型中探索了 LIR 的潜在抗癫痫发生作用;即,内侧海马海人酸(KA)诱导的颞叶癫痫模型和 WAG/Rij 大鼠的失神发作发生模型。此外,我们还在各种行为测试中评估了 LIR 对合并症的影响。用 LIR(300μg/kg/天 sc)治疗海人酸诱导的癫痫小鼠,在癫痫持续状态后 4 周进行治疗,然后评估药物对癫痫发作发展和行为改变的影响,而 WAG/Rij 大鼠则用 LIR(300μg/kg/天 sc)治疗 17 周(在发病前 30 天开始),以研究早期慢性治疗是否能够减少失神发作的发展和相关合并症。我们的结果表明,LIR 有效降低了海人酸诱导癫痫中自发性癫痫的发展;此外,在该模型中,它预防了开放场(OF)测试中的记忆障碍和相关焦虑样行为,而在强迫游泳测试(FST)中,LIR 显示出明显的抗抑郁作用,而这种作用与耐力下降有关,旋转棒测试证实了这一点。相比之下,LIR 不能改变 WAG/Rij 大鼠中失神发作发展背后的致癫痫过程,而在该大鼠的 FST 中具有抗抑郁作用。我们的结果表明,LIR 可能代表一种有前途的新型治疗方法,可预防和治疗一些以神经退行性变为特征的惊厥性癫痫模型中的致癫痫过程及其相关的行为和认知改变,因为 LIR 的作用可能继发于其公认的神经保护特性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验